The cost of Biogen’s new drug: $750,000 per patient
The medication for a rare disorder will be Biogen’s costliest yet, generating $1 billion per year in sales
The medication for a rare disorder will be Biogen’s costliest yet, generating $1 billion per year in sales
以上內容由「Cofacts 真的假的」訊息回報機器人與查證協作社群提供,以 CC授權 姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出,於後續重製或散布時,原社群顯名及每一則查證的出處連結皆必須被完整引用。